AQR Capital Management’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$96.7K Buy
26,061
+11,721
+82% +$43.5K ﹤0.01% 3182
2025
Q1
$46.3K Buy
+14,340
New +$46.3K ﹤0.01% 3084